Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) has issued an announcement.
MicroTech Medical (Hangzhou) Co., Ltd. has amended the terms of reference for its Nomination Committee to enhance corporate governance and optimize the composition of its Board of Directors. The committee is tasked with setting selection criteria for directors and senior management, ensuring diversity and skills alignment with the company’s strategic goals, and maintaining compliance with relevant regulations.
The most recent analyst rating on (HK:2235) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. operates in the medical technology industry, focusing on the development and provision of medical devices and solutions. The company is primarily engaged in the production of innovative medical products aimed at improving healthcare delivery and patient outcomes.
Average Trading Volume: 98,600
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.53B
See more insights into 2235 stock on TipRanks’ Stock Analysis page.